Annovis Bio, Inc. (ANVS) AI Dilution Summary

Estimated cash was $18,728,945 as of 2026-06-30 against estimated monthly burn of $5,154,207, with funding through the active ATM program with Oppenheimer & Co. Inc., authorised to $50,000,000. ATM sales through 2026-06-30, the most recent capital raised, total 4,326,821 shares since the program began; sales after 2026-06-30 not yet reported.